Latest Financials News

Fisher & Paykel Healthcare has issued strong first half FY26 guidance, forecasting significant revenue and profit growth while navigating new US tariffs. Meanwhile, director Pip Greenwood announces her retirement after eight years on the board.

Turners Automotive Group has reported a record FY25 financial performance, with net profit after tax rising 17% to $38.6 million and dividends increasing 14% to 29.0 cents per share, underscoring resilience amid a challenging New Zealand economy.

Auckland International Airport reported a 12% revenue increase to NZD 1 billion and a 12% rise in underlying profit, driven by growing passenger numbers and strong commercial performance. The airport is progressing a major infrastructure program while achieving significant emissions reductions.

Kaili Resources Limited has resumed trading on the ASX following a suspension triggered by regulatory queries. The company’s prompt response to ASX concerns has cleared the way for its securities to re-enter the market.

Kaili Resources has officially confirmed a change of control with Mr Jianzhong Yang now holding over 60% of shares, alongside a significant board reshuffle. The company remains focused on advancing its rare earth elements exploration in South Australia.

Complii FinTech Solutions has posted a 28.7% increase in revenue for FY25 alongside a significant reduction in net loss, triggering the vesting of over 20 million performance rights.

Artrya Limited reported a 17.2% increase in net loss to $16.4 million for FY25, while achieving FDA clearance and launching its AI-driven Salix platform in the U.S. market. The company also secured key commercial partnerships in Australia and raised $20 million in equity funding.

Euroz Hartleys Group Limited reported a robust 87.7% increase in net profit for FY25, driven by growth across brokerage, underwriting, and wealth management. The company declared a fully franked full-year dividend of 5.5 cents per share, reflecting confidence in its operational leverage and balance sheet strength.

Alliance Aviation Services reported a robust 19% revenue increase to $769.7 million in FY25, driven by fleet expansion and strong operational performance. The company’s strategic investments and contract growth set a positive tone for FY26.

Alliance Aviation Services reported record flying hours and strong revenue growth in FY25, while statutory profit dipped slightly amid operational challenges.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.

Alliance Aviation Services Limited reported a 19% revenue increase to $760.9 million in FY2025, while net profit after tax slipped 5% to $57.3 million amid operational challenges. The company declared a fully franked dividend of 3.0 cents per share and expanded its fleet to 79 aircraft.